Skip to Content Facebook Feature Image

Sharon AI Reports Second Quarter 2026 Results

Business

Sharon AI Reports Second Quarter 2026 Results
Business

Business

Sharon AI Reports Second Quarter 2026 Results

2026-08-06 19:00 Last Updated At:19:15

Total contract value reaches ~$8.8bn 

Six-year strategic NVIDIA compute collaboration

Secured AI Factory capacity increases by 80MW to 212MW

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Sharon AI Holdings Inc. (NASDAQ: SHAZ) and its subsidiaries ("Sharon AI" or "the Company"), a leading Australian Neocloud, today reported its financial and operational results for the second quarter ended June 30, 2026.

All amounts are in U.S. dollars unless otherwise indicated.

Second Quarter 2026 Highlights

  • Customer Momentum
    • $4.9bn, six-year strategic compute collaboration with NVIDIA for up to 40,000 GB300 GPUs
    • $950m, five-year, take-or-pay contract with a global technology company with major Asia-pacific presence
  • Capacity and Platform
    • Expanded VAST Data partnership: 600PB VAST AI Operating System deployed as the foundational data layer, sized to support ~100,000 GPUs
  • Balance Sheet and Capital
    • Well funded for the near-term build-out following the $1.6bn oversubscribed private placement, $350m convertible notes offering, and the accelerated receipt of $74m in proceeds from the divestment of Texas Critical Data Centers ("TCDC")
  • Leadership and Governance
    • Appointed Andrew Penn AO as Non-Executive Chairman

  • $4.9bn, six-year strategic compute collaboration with NVIDIA for up to 40,000 GB300 GPUs
  • $950m, five-year, take-or-pay contract with a global technology company with major Asia-pacific presence

  • Expanded VAST Data partnership: 600PB VAST AI Operating System deployed as the foundational data layer, sized to support ~100,000 GPUs

  • Well funded for the near-term build-out following the $1.6bn oversubscribed private placement, $350m convertible notes offering, and the accelerated receipt of $74m in proceeds from the divestment of Texas Critical Data Centers ("TCDC")

  • Appointed Andrew Penn AO as Non-Executive Chairman

Second Quarter 2026 Financial Results

  • Revenue: $1.9m, an increase of 412% from 2Q 2025
  • Net income (loss): $(430.4m), including non-cash items totaling $423.8m, primarily reflecting a $400.4m fair value loss on convertible notes resulting from share price appreciation, compared to a net loss of $(2.6m) in 2Q 2025.
  • Adjusted EBITDA1: $0.6m, compared to $(1.7m) in 2Q 2025
  • Cash and cash equivalents: $1.9bn at June 30, 2026
  • Total Contract Value ("TCV")2: $8.8bn as of August 6, 2026

1Adjusted EBITDA is a non-GAAP financial measure. See "Non-GAAP Financial Measures" and reconciliation tables.

2TCV represents the aggregate estimated contractual committed spend under customer contracts in effect as of the measurement date, for the contractual term. TCV is an operating metric and does not represent revenue recognized in accordance with U.S. GAAP. TCV excludes contracts that are not legally binding and is subject to change based on contract modifications, terminations, and other factors.

1Adjusted EBITDA is a non-GAAP financial measure. See "Non-GAAP Financial Measures" and reconciliation tables.

2TCV represents the aggregate estimated contractual committed spend under customer contracts in effect as of the measurement date, for the contractual term. TCV is an operating metric and does not represent revenue recognized in accordance with U.S. GAAP. TCV excludes contracts that are not legally binding and is subject to change based on contract modifications, terminations, and other factors.

Management Commentary

"In the second quarter, we established the commercial, infrastructure, and capital foundations for Sharon AI's next phase of growth at scale," said James Manning, Co-Founder and Chief Executive Officer of Sharon AI. "Customer engagement continues to broaden and deepen, reflecting strong demand for secure, high-performance AI infrastructure and a growing recognition that access to power, compute and data sovereignty will be critical constraints as AI adoption accelerates.

"Our focus is on converting that demand and our contracted commitments into durable revenue growth and long-term shareholder value through disciplined execution. We are on track to bring contracted capacity online in accordance with our deployment schedule, while maintaining a thoughtful approach to capital allocation and pace of expansion. Revenue is expected to ramp materially from the third quarter of 2026 through 2027. With an experienced leadership team backed by deep technical and operating expertise across the business, a best-in-class partner ecosystem and a strengthened balance sheet, we believe Sharon AI is well positioned to become a leading sovereign AI infrastructure platform across Australia, New Zealand, and the broader Asia-Pacific region."

Subsequent Highlights

In the third quarter 2026 to-date, the Company has announced:

  • $1.32bn, five-year, take-or-pay contract with a global AI lab, anchoring Sharon AI's expansion to New Zealand
  • Additional 80MW of capacity, bringing total capacity to 212MW, for deployment in 2026 and 2027, underpinned by a growing pipeline of additional capacity
  • $373m, five-year, take-or-pay contract with a global AI platform for a deployment of 2,048 NVIDIA B300 GPUs
  • 64,000+ NVIDIA GPUs expected to be deployed by mid 2027
  • Anuj Goel as Chief Financial Officer and Melissa Anastasiou as Chief Legal Officer

2Q 2026 Results Conference Call & Webcast

Date & Time: Thursday, August 6, 2026, 4:30 p.m. ET
Webcast: Use this link
U.S. Dial-in: 888-506-0062
International Dial-in: +1-973-528-0011
Conference ID: 376509

A replay of the webcast will be available at sharonai.com/investors following the event.

About Sharon AI

Sharon AI (NASDAQ: SHAZ) is a leading Australian neocloud expanding access to artificial intelligence through trusted, secure and sovereign AI infrastructure. Through its AI Factory platform and colocation partners, Sharon AI enables organisations across Australia, New Zealand, and globally to confidently build, train and deploy AI at scale. For more information, visit www.sharonai.com.

Disclosure Information

Sharon AI primarily uses its Investor Relations page (https://sharonai.com/investors/) to disclose material non-public information and to comply with its disclosure obligations under Regulation FD. The Company also notes that, at times, it uses other communication mediums including, but not limited to, its X account (sharon__ai) and/or LinkedIn account (sharon-AI) to disseminate information about the Company, and can be additional sources of information outside press releases, regulatory filings with the SEC and any other conference calls, webcasts, investor days, etc. that the company may hold.

Forward-Looking Statements

This press release may contain, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which are not historical facts, and which are not assurances of future performance. Forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. In some cases you can identify these statements by forward-looking words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "could," "should," "would," "project," "strategy," "plan," "expect," "goal," "seek," "future," "likely" or the negative or plural of these words or similar expressions or references to future periods. Forward-looking statements in this release include specific statements regarding the intended use of proceeds. Examples of such forward-looking statements include but are not limited to express or implied statements regarding Sharon AI's management team's expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding:

  • Service and product offerings;
  • Receipt and use of proceeds;
  • The deployment of assets and expansion of network procurement;
  • Sharon AI's ability to engage with additional potential customers;
  • Expansion of Sharon AI's data center footprint and capacity; and
  • The strengthening of Sharon AI's partner network.

In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results to differ materially from these forward-looking statements include, among others, all of the risks described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the SEC and other reports subsequently filed with the SEC. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the SEC, which are available at www.sec.gov

The forward-looking statements and other information contained in this news release are made as of the date hereof and Sharon AI does not undertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

NonGAAP Financial Measures

This press release includes "Adjusted EBITDA," which is a non–GAAP financial measure. The Company defines Adjusted EBITDA as net income (loss) adjusted to exclude: (i) interest expense (income), net; (ii) income tax expense (benefit); (iii) depreciation and amortization; (iv) stock-based compensation expense; (v) fair value adjustments on convertible notes; and (vi) other non-cash or non-recurring items that management does not consider indicative of the Company's ongoing operating performance. Adjusted EBITDA is not a substitute for net income (loss) or any other measure of financial performance prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. Management believes Adjusted EBITDA is useful to investors because it provides a supplemental measure of the Company's core operating performance by excluding the effects of capital structure decisions (such as interest expense and fair value changes on convertible notes), non-cash charges (such as depreciation, amortization and stock-based compensation), and tax impacts that can vary significantly between periods and across companies. Management uses Adjusted EBITDA to evaluate the Company's performance, compare performance across periods, and assist in the allocation of resources. Investors are cautioned that Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of the Company's results as reported under U.S. GAAP.

A reconciliation of Adjusted EBITDA to the most directly comparable U.S. GAAP financial measure is included in the tables accompanying this press release. To the extent the Company provides forward-looking Adjusted EBITDA guidance in connection with this release or the related earnings call, a reconciliation of such forward-looking non-GAAP measure to the most directly comparable U.S. GAAP measure may not be available without unreasonable effort due to the inherent difficulty in forecasting and quantifying certain amounts, including but not limited to fair value adjustments on convertible notes, stock-based compensation expense, and other non-cash or non-recurring items, the timing and magnitude of which may be significant.

Contacts

Media
media@sharonai.com

Investors
investors@sharonai.com

 

CONSOLIDATED CONDENSED BALANCE SHEETS

June 30,

December 31,

2026

2025

(unaudited)

ASSETS

Current assets

Cash and cash equivalents

$

1,861,347,822

$

71,073,024

Trade and other receivables

28,458,817

749,677

Convertible note proceeds receivable

-

15,171,072

Assets held for sale

1,170,289

1,135,490

Other current assets

47,196,444

288,191

Total current assets

1,938,173,372

88,417,454

Property and equipment, net

26,323,307

15,207,775

Right of use assets, net

6,889,203

7,140,877

Equipment, software and lease prepayments

302,647,678

-

Certificates of deposits

12,748,105

915,397

Other long-term assets

16,512,329

3,414,432

Goodwill

18,044,215

18,044,215

TOTAL ASSETS

$

2,321,338,209

$

133,140,150

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities

Trade and other payables

$

32,407,955

$

3,433,320

Customer deposits

143,879,911

-

Warrant liability

6,145,450

890,000

Note payable

-

2,254,968

SAFE note liability

6,025

-

Convertible notes

1,006,535,059

129,017,286

Finance lease liabilities, current portion

1,176,406

1,072,820

Other current liabilities

-

2,701,932

Total current liabilities

1,190,150,806

139,370,326

Finance lease liabilities, non-current

3,640,024

3,918,081

TOTAL LIABILITIES

1,193,790,830

143,288,407

Stockholders' equity (deficit):

Common Stock- Class A ($0.001 par value, 900,000,000 shares
authorized; 35,667,164 and 11,832,164 shares issued and
outstanding as of June 30, 2026 and December 31, 2025,
respectively)

3,567

1,183

Common Stock- Class B ($0.0001 par value, 6,891,948 shares
authorized; 136,341 shares issued and outstanding as of June
30, 2026 and December 31, 2025)

14

14

   Common Stock, value

14

14

Additional paid-in capital

1,624,995,090

33,861,613

Accumulated deficit

(491,747,880)

(43,529,190)

Accumulated other comprehensive loss

(3,418,013)

(372,992)

Noncontrolling interest

(2,285,399)

(108,885)

TOTAL STOCKHOLDERS' EQUITY (DEFICIT)

1,127,547,379

(10,148,257)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

$

2,321,338,209

$

133,140,150

CONSOLIDATED CONDENSED BALANCE SHEETS

June 30,

December 31,

2026

2025

(unaudited)

ASSETS

Current assets

Cash and cash equivalents

$

1,861,347,822

$

71,073,024

Trade and other receivables

28,458,817

749,677

Convertible note proceeds receivable

-

15,171,072

Assets held for sale

1,170,289

1,135,490

Other current assets

47,196,444

288,191

Total current assets

1,938,173,372

88,417,454

Property and equipment, net

26,323,307

15,207,775

Right of use assets, net

6,889,203

7,140,877

Equipment, software and lease prepayments

302,647,678

-

Certificates of deposits

12,748,105

915,397

Other long-term assets

16,512,329

3,414,432

Goodwill

18,044,215

18,044,215

TOTAL ASSETS

$

2,321,338,209

$

133,140,150

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities

Trade and other payables

$

32,407,955

$

3,433,320

Customer deposits

143,879,911

-

Warrant liability

6,145,450

890,000

Note payable

-

2,254,968

SAFE note liability

6,025

-

Convertible notes

1,006,535,059

129,017,286

Finance lease liabilities, current portion

1,176,406

1,072,820

Other current liabilities

-

2,701,932

Total current liabilities

1,190,150,806

139,370,326

Finance lease liabilities, non-current

3,640,024

3,918,081

TOTAL LIABILITIES

1,193,790,830

143,288,407

Stockholders' equity (deficit):

Common Stock- Class A ($0.001 par value, 900,000,000 shares
authorized; 35,667,164 and 11,832,164 shares issued and
outstanding as of June 30, 2026 and December 31, 2025,
respectively)

3,567

1,183

Common Stock- Class B ($0.0001 par value, 6,891,948 shares
authorized; 136,341 shares issued and outstanding as of June
30, 2026 and December 31, 2025)

14

14

   Common Stock, value

14

14

Additional paid-in capital

1,624,995,090

33,861,613

Accumulated deficit

(491,747,880)

(43,529,190)

Accumulated other comprehensive loss

(3,418,013)

(372,992)

Noncontrolling interest

(2,285,399)

(108,885)

TOTAL STOCKHOLDERS' EQUITY (DEFICIT)

1,127,547,379

(10,148,257)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

$

2,321,338,209

$

133,140,150

 

 

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)

2026

2025

2026

2025

For the Three Months
Ended
June 30,

For the Six Months Ended
June 30,

2026

2025

2026

2025

Revenue

$

1,931,381

$

376,984

$

2,225,396

$

702,077

Cost of revenue

761,755

398,266

1,287,572

711,648

Gross profit (loss)

1,169,626

(21,282)

937,824

(9,571)

Share-based compensation

2,670,588

489,345

3,052,746

956,968

Selling, general and administrative expenses

8,685,424

1,083,093

12,700,643

2,090,523

Other expenses

14,597,792

1,169,712

12,787,838

1,676,132

Other income

-

(153,199)

-

(961,713)

Loss from operations

(24,784,178)

(2,610,233)

(27,603,403)

(3,771,481)

Non-operating income (expense), net:

Change in fair value of digital assets

-

(62,657)

-

(391,090)

Change in fair value of warrant liabilities

(6,138,775)

-

(5,255,450)

-

Change in fair value of convertible notes

(400,440,855)

-

(470,668,608)

-

Change in fair value of share-based payment

334,502

-

334,502

-

Gain on investment in NUAI shares

6,493,245

-

4,984,130

-

Gain on sale of investment in TCDC

856

-

65,920,568

-

Interest income (expense), net

(4,527,540)

(43,521)

(3,267,654)

(55,912)

Loss before income taxes

(429,062,745)

(2,716,411)

(435,555,915)

(4,218,483)

Income tax (expense) benefit

(1,305,951)

127,579

(14,824,603)

190,161

Net loss

(430,368,696)

(2,588,832)

(450,380,518)

(4,028,322)

Net loss attributable to non-controlling interest

(2,065,770)

(12,426)

(2,161,826)

(19,336)

Net loss attributable to SharonAI Holdings
Inc.

$

(428,302,926)

$

(2,576,406)

$

(448,218,692)

$

(4,008,986)

Net loss per share, basic and diluted

$

(26.16)

$

(2.41)

$

(27.38)

$

(3.76)

Weighted-average number of shares
outstanding

16,370,481

1,067,213

16,370,481

1,067,213

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)

2026

2025

2026

2025

For the Three Months
Ended
June 30,

For the Six Months Ended
June 30,

2026

2025

2026

2025

Revenue

$

1,931,381

$

376,984

$

2,225,396

$

702,077

Cost of revenue

761,755

398,266

1,287,572

711,648

Gross profit (loss)

1,169,626

(21,282)

937,824

(9,571)

Share-based compensation

2,670,588

489,345

3,052,746

956,968

Selling, general and administrative expenses

8,685,424

1,083,093

12,700,643

2,090,523

Other expenses

14,597,792

1,169,712

12,787,838

1,676,132

Other income

-

(153,199)

-

(961,713)

Loss from operations

(24,784,178)

(2,610,233)

(27,603,403)

(3,771,481)

Non-operating income (expense), net:

Change in fair value of digital assets

-

(62,657)

-

(391,090)

Change in fair value of warrant liabilities

(6,138,775)

-

(5,255,450)

-

Change in fair value of convertible notes

(400,440,855)

-

(470,668,608)

-

Change in fair value of share-based payment

334,502

-

334,502

-

Gain on investment in NUAI shares

6,493,245

-

4,984,130

-

Gain on sale of investment in TCDC

856

-

65,920,568

-

Interest income (expense), net

(4,527,540)

(43,521)

(3,267,654)

(55,912)

Loss before income taxes

(429,062,745)

(2,716,411)

(435,555,915)

(4,218,483)

Income tax (expense) benefit

(1,305,951)

127,579

(14,824,603)

190,161

Net loss

(430,368,696)

(2,588,832)

(450,380,518)

(4,028,322)

Net loss attributable to non-controlling interest

(2,065,770)

(12,426)

(2,161,826)

(19,336)

Net loss attributable to SharonAI Holdings
Inc.

$

(428,302,926)

$

(2,576,406)

$

(448,218,692)

$

(4,008,986)

Net loss per share, basic and diluted

$

(26.16)

$

(2.41)

$

(27.38)

$

(3.76)

Weighted-average number of shares
outstanding

16,370,481

1,067,213

16,370,481

1,067,213

 

 

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)

2026

2025

For the Six Months Ended

June 30,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss for the period, including noncontrolling interest

$

(450,380,518)

$

(4,028,322)

Adjustments to reconcile net income (loss) to net cash provided by (used in)
operating activities:

Depreciation

3,199,299

803,955

Share based compensation

3,052,746

956,968

Change in fair value of digital assets

-

391,090

Intangible assets (FIL) revenue

-

(130,154)

Intangible assets (FIL) cost of revenue

-

138,070

Accelerated amortization of Intangible assets

-

1,650,000

Deferred tax liability

-

89,050

Unrealized (gains) losses on foreign currency exchange

11,122,667

(731,755)

Change in fair value of warrant liability

5,255,450

-

Change in fair value of convertible notes

470,668,608

-

Gain (loss) on investment in NUAI shares

(4,984,130)

-

Gain on sale of investment in TCDC

(65,920,568)

-

Interest income on convertible note receivable

(1,342,466)

-

Gain on sale of property and equipment

-

(961,713)

Bad debt expense

-

76,748

Changes in assets and liabilities:

Trade and other receivables

(26,712,905)

932,259

Customer deposits

143,879,911

-

Other current assets

(95,762,765)

(24,689)

Other long-term assets

(2,212,252)

9,355

Trade and other payables

24,231,858

(879,313)

Income tax payable

7,803,779

-

Interest received from convertible note receivable

1,342,466

-

Net cash provided by (used in) operating activities

23,241,180

(1,708,451)

CASH FLOWS FROM INVESTING ACTIVITIES

Advance payments for property and equipment

(310,665,524)

-

Purchase of certificates of deposit

(11,804,654)

-

Payment for the purchase of property and equipment

(12,541,952)

(37,343)

Payment for land purchase

(3,136,000)

-

Cash proceeds from sale of TCDC investment

9,850,000

-

Proceeds from sale of NUAI Shares

14,984,130

-

Proceeds from convertible note receivable

50,000,000

-

Proceeds from sales of digital assets

-

93,051

Net cash provided by (used in) investing activities

(263,314,000)

55,708

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of common stock

586,858,433

-

Cash received from convertible note issuance

1,065,636,015

-

Issuance costs related to capital raise

(43,500,602)

-

Proceeds from exercise of warrants

370

-

Proceeds from issuance of pre-funded warrants

438,141,548

-

Payment for lease liabilities

(712,210)

(284,491)

Repayment of note payable

(2,249,124)

-

Net cash provided by (used in) financing activities

2,044,174,430

(284,491)

Effect of exchange rate changes on cash and cash equivalents

(13,826,812)

(81,793)

Net cash increase/(decreases) in cash and cash equivalents

1,790,274,798

(2,019,027)

Cash and cash equivalents at beginning of period

71,073,024

4,424,805

Cash and cash equivalents at end of period

$

1,861,347,822

$

2,405,778

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)

2026

2025

For the Six Months Ended

June 30,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss for the period, including noncontrolling interest

$

(450,380,518)

$

(4,028,322)

Adjustments to reconcile net income (loss) to net cash provided by (used in)
operating activities:

Depreciation

3,199,299

803,955

Share based compensation

3,052,746

956,968

Change in fair value of digital assets

-

391,090

Intangible assets (FIL) revenue

-

(130,154)

Intangible assets (FIL) cost of revenue

-

138,070

Accelerated amortization of Intangible assets

-

1,650,000

Deferred tax liability

-

89,050

Unrealized (gains) losses on foreign currency exchange

11,122,667

(731,755)

Change in fair value of warrant liability

5,255,450

-

Change in fair value of convertible notes

470,668,608

-

Gain (loss) on investment in NUAI shares

(4,984,130)

-

Gain on sale of investment in TCDC

(65,920,568)

-

Interest income on convertible note receivable

(1,342,466)

-

Gain on sale of property and equipment

-

(961,713)

Bad debt expense

-

76,748

Changes in assets and liabilities:

Trade and other receivables

(26,712,905)

932,259

Customer deposits

143,879,911

-

Other current assets

(95,762,765)

(24,689)

Other long-term assets

(2,212,252)

9,355

Trade and other payables

24,231,858

(879,313)

Income tax payable

7,803,779

-

Interest received from convertible note receivable

1,342,466

-

Net cash provided by (used in) operating activities

23,241,180

(1,708,451)

CASH FLOWS FROM INVESTING ACTIVITIES

Advance payments for property and equipment

(310,665,524)

-

Purchase of certificates of deposit

(11,804,654)

-

Payment for the purchase of property and equipment

(12,541,952)

(37,343)

Payment for land purchase

(3,136,000)

-

Cash proceeds from sale of TCDC investment

9,850,000

-

Proceeds from sale of NUAI Shares

14,984,130

-

Proceeds from convertible note receivable

50,000,000

-

Proceeds from sales of digital assets

-

93,051

Net cash provided by (used in) investing activities

(263,314,000)

55,708

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of common stock

586,858,433

-

Cash received from convertible note issuance

1,065,636,015

-

Issuance costs related to capital raise

(43,500,602)

-

Proceeds from exercise of warrants

370

-

Proceeds from issuance of pre-funded warrants

438,141,548

-

Payment for lease liabilities

(712,210)

(284,491)

Repayment of note payable

(2,249,124)

-

Net cash provided by (used in) financing activities

2,044,174,430

(284,491)

Effect of exchange rate changes on cash and cash equivalents

(13,826,812)

(81,793)

Net cash increase/(decreases) in cash and cash equivalents

1,790,274,798

(2,019,027)

Cash and cash equivalents at beginning of period

71,073,024

4,424,805

Cash and cash equivalents at end of period

$

1,861,347,822

$

2,405,778

 

 

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited) 

For the Three Months Ended

June 30,

 $ in thousands

2026

2025

Net loss

$

(430,369)

$

(2,589)

+ Income tax expense (benefit)

1,306

(128)

+ Net interest expense (income)

4,528

44

+ Depreciation

1,881

439

EBITDA

(422,654)

(2,234)

+ Share-based compensation

2,671

489

+ Change in fair value of convertible notes

400,441

-

+ Change in fair value of warrant liabilities

6,139

-

+ Change in fair value of digital assets

-

63

+ Unrealized Foreign currency gain

14,329

-

+ Change in fair value of share-based payment

(335)

-

Adjusted EBITDA (Non-GAAP)

$

591

$

(1, 682)

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(Unaudited) 

For the Three Months Ended

June 30,

 $ in thousands

2026

2025

Net loss

$

(430,369)

$

(2,589)

+ Income tax expense (benefit)

1,306

(128)

+ Net interest expense (income)

4,528

44

+ Depreciation

1,881

439

EBITDA

(422,654)

(2,234)

+ Share-based compensation

2,671

489

+ Change in fair value of convertible notes

400,441

-

+ Change in fair value of warrant liabilities

6,139

-

+ Change in fair value of digital assets

-

63

+ Unrealized Foreign currency gain

14,329

-

+ Change in fair value of share-based payment

(335)

-

Adjusted EBITDA (Non-GAAP)

$

591

$

(1, 682)

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Sharon AI Reports Second Quarter 2026 Results

Sharon AI Reports Second Quarter 2026 Results

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Ascentiz, a pioneer in consumer wearable exoskeleton technology and creator of the world's first modular exoskeleton, today announced the commercial availability of the Ascentiz H Series. The H Pro and H Ultra are now available for direct purchase through the Ascentiz online store, bringing the company's modular mobility platform from early adoption and real-world testing into broader everyday use.

Designed for walking, hiking, running, cycling, stair climbing, and urban exploration, the H Series delivers responsive assistance at the hips while staying compact enough for travel and daily wear. Rather than replacing the wearer's natural movement, the system syncs with gait and movement intent, assisting key phases of each step, such as lifting the leg forward and pushing off from the ground.

Built for an Evolving Modular Ecosystem

Ascentiz built its system around one shared Exo-Belt with interchangeable assistance modules. The H module handles hip propulsion and responsive movement assistance; the K module, in mass production, is designed for sustained knee support and impact management on descents.

Through BodyOS™, Ascentiz plans to support additional hardware modules, software functions, and developer-built applications over time. The H Ultra includes an expanded open-source SDK, letting developers and third parties build customised functions and new applications through the platform's software tools and hardware interfaces.

Adaptive Motion Intelligence That Moves With the Wearer

The H Series is available in two configurations.

H Pro is designed for everyday mobility, fitness and lighter outdoor activities, offering a balance of portability, intelligent assistance and up to 25 kilometers of assisted range.

H Ultra is built for longer, more demanding journeys. Carbon fibre and a titanium-alloy Exo-Belt give it a premium, durable build, and a dual-battery system extends assisted range to 50 kilometres. It also offers greater power output and expanded motion recognition.

Both models feature a compact, lightweight design, quiet operation, and IP54 protection, making the system suitable across a range of everyday and outdoor environments.

Ascentiz aims to make wearable robotics practical for real-world use, with technology that feels like a natural extension of the body. The company's mission is to help people move with less effort while staying in full control, so they can go farther and explore more of everyday life and the outdoors.

Pricing and Availability

The Ascentiz H Pro has an MSRP of $1,499, while the Ascentiz H Ultra has an MSRP of $1,999. Product pricing, promotions and availability may vary by market and purchasing period. Customers can view model comparisons, sizing information and purchasing details at ascentizexo.com.

The Ascentiz H Series is designed to reduce effort and support natural movement, cutting the work of walking by up to 35% so wearers can move freely for longer. It is not a medical device and is not intended for clinical diagnosis or treatment.

Ascentiz will also showcase the commercially available H Series at IFA Berlin 2026, beginning September 4, with hands-on demonstrations at Hall 12, Booth 109. Visitors can try the H Series, preview the upcoming K module, and see developer demonstrations of customised applications and new use cases built on the Ascentiz platform.

About Ascentiz

Founded in 2023, Ascentiz is dedicated to transforming advanced robotics into accessible, user-centric exoskeleton technology. Our mission is to empower individuals to climb higher, go further, and unlock new physical potentials in their everyday lives and adventures. We believe in augmentation without complexity, creating lightweight, intuitive interfaces that seamlessly integrate into any lifestyle.

Learn more at ascentizexo.com.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Ascentiz Launches H Series Modular Exoskeleton for Everyday and Outdoor Mobility

Ascentiz Launches H Series Modular Exoskeleton for Everyday and Outdoor Mobility

Recommended Articles